| Literature DB >> 34398663 |
Carolyn J Hovde1, Scott A Minnich1, Anna M Kolodziejek2, Gregory A Bohach2.
Abstract
Maintenance of phospholipid (PL) and lipopoly- or lipooligosaccharide (LPS or LOS) asymmetry in the outer membrane (OM) of Gram-negative bacteria is essential but poorly understood. The Yersinia pestis OM Ail protein was required to maintain lipid homeostasis and cell integrity at elevated temperature (37°C). Loss of this protein had pleiotropic effects. A Y. pestis Δail mutant and KIM6+ wild type were systematically compared for (i) growth requirements at 37°C, (ii) cell structure, (iii) antibiotic and detergent sensitivity, (iv) proteins released into supernatants, (v) induction of the heat shock response, and (vi) physiological and genetic suppressors that restored the wild-type phenotype. The Δail mutant grew normally at 28°C but lysed at 37°C when it entered stationary phase, as shown by cell count, SDS-PAGE of cell supernatants, and electron microscopy. Immunofluorescence microscopy showed that the Δail mutant did not assemble Caf1 capsule. Expression of heat shock promoter rpoE or rpoH fused to a lux operon reporter were not induced when the Δail mutant was shifted from 28°C to 37°C (P < 0.001 and P < 0.01, respectively). Mutant lysis was suppressed by addition of 11 mM glucose, 22 or 44 mM glycerol, 2.5 mM Ca2+, or 2.5 mM Mg2+ to the growth medium or by a mutation in the phospholipase A gene (pldA::miniTn5, ΔpldA, or PldAS164A). A model accounting for the temperature-sensitive lysis of the Δail mutant and the Ail-dependent stabilization of the OM tetraacylated LOS at 37°C is presented. IMPORTANCE The Gram-negative pathogen Yersinia pestis transitions between a flea vector (ambient temperature) and a mammalian host (37°C). In response to 37°C, Y. pestis modifies its outer membrane (OM) by reducing the fatty acid content in lipid A, changing the outer leaflet from being predominantly hexaacylated to being predominantly tetraacylated. It also increases the Ail concentration, so it becomes the most prominent OM protein. Both measures are needed for Y. pestis to evade the host innate immune response. Deletion of ail destabilizes the OM at 37°C, causing the cells to lyse. These results show that a protein is essential for maintaining lipid asymmetry and lipid homeostasis in the bacterial OM.Entities:
Keywords: Ail; LPS; PldA; Yersinia pestis; heat shock response; lysis; membrane homeostasis; phospholipid; thermosensitivity
Mesh:
Substances:
Year: 2021 PMID: 34398663 PMCID: PMC8508112 DOI: 10.1128/JB.00361-21
Source DB: PubMed Journal: J Bacteriol ISSN: 0021-9193 Impact factor: 3.490
FIG 1Y. pestis Δail mutant released proteins and lysed in stationary phase at 37°C. Y. pestis KIM6+ wild type, the Δail mutant, and the Δail/ail complemented strain were grown with aeration to late stationary phase at 37°C or 28°C in Luria-Bertani (LB) broth. (A) Growth measured by OD600 shows that only the Δail mutant grown at 37°C had a significant decrease in turbidity. (B) Cell-free supernatants from cultures grown for 24 h/37°C were ethanol precipitated, separated by 12.5% SDS-PAGE, and stained with Coomassie blue (bench mark standards [BM] on left). Only the Δail mutant grown at 37°C shows increased amounts of proteins released into the medium. (C) Representative transmission electron microscopy of 24 h/37°C cultures of KIM6+ and the Δail mutant are shown. The Δail mutant had increased cell ghosts (arrow) and released debris. (D) Ail or Ail homologues in Y. pestis KIM6+ wild type, the Δail mutant, and the Δail mutant complemented with y1324 (control), y2034, or y2446; cells were grown to mid-exponential phase in medium with 1 mM IPTG. SDS-PAGE of whole-cell lysates stained with Coomassie blue, 15- to 20-kDa range shown. (E) Proteins released from cells as indicated in panel D. Cell-free supernatants were prepared as described for panel B, and BM standard positions are indicated on the left. Only KIM6+ and the Δail mutant expressing y1324 did not release increased amounts of protein into the supernatant.
Antibiotic and SDS susceptibility of Y. pestis KIM6+ and the Δail mutant
| Compound | MIC | |
|---|---|---|
| KIM6+ | ||
| Vancomycin | >4,000 | >4,000 |
| Novobiocin | 50 | 100 |
| Polymyxin B | 1,000 | 250 |
| SDS | 226 | 329 |
MICs are for vancomycin, novobiocin, and polymyxin B.
IC50, half-maximal inhibitory concentration, applies only to SDS.
Y. pestis grown in LB broth at 37°C for 24 h.
Sodium dodecyl sulphate.
FIG 2Y. pestis Δail mutant grown at 37°C had membrane defects in stationary phase. Y. pestis KIM6+ wild type and the Δail mutant were grown with aeration at 37°C in Luria-Bertani (LB) broth. Representative transmission electron micrographs of cells in the logarithmic phase (OD600 of 0.6) or 24 h at stationary phase are shown. In logarithmic phase, both cell types retained continuous membranes with no visible breaks or inner membrane retraction (A), but the Δail mutant released cellular matter into the supernatant (arrow) (B). In stationary phase, the Δail mutant had increased central cytoplasmic density, retracted inner membranes, enlarged periplasmic spaces (arrow) (C) and bursting cells with retracted inner membranes (arrow) (E). (F) In stationary phase, both KIM6+ wild type and the Δail mutant had swollen ghost cells with decreased density. (D) Percent plasmolyzed cells was quantified from 21 electron micrographs; results are means ± standard errors (SE); an asterisk indicates statistical difference (Student's t test, P < 0.05).
FIG 3Y. pestis Δail mutant lysis at 37°C was prevented by glucose, glycerol, Ca2+, or Mg2+. Y. pestis KIM6+ wild type, the Δail mutant, and the Δail/ail complemented strain were grown with aeration to late stationary phase (48 h/37°C) in Luria-Bertani (LB) broth with or without carbohydrate or divalent cations. (A) Cell-free supernatants from cultures grown with or without 11 mM glucose, sorbitol, xylose, or ribose, as indicated, were ethanol precipitated, separated by 12.5% SDS-PAGE, and stained with Coomassie blue. Protein bench mark standard positions are indicated on the left. Only growth with glucose decreased the amounts of protein released into the medium by Y. pestis Δail mutant. (B) The protein content of cell-free supernatants from cultures grown with or without 22 mM or 44 mM glycerol was quantified by Bradford assays. Both glycerol concentrations decreased the amounts of protein released into the medium by Y. pestis Δail mutant. (C) After growth in LB with or without CaCl2 or MgCl2 (2.5 mM), numbers of CFU per milliliter were determined by plate count. Growth with either divalent cation prevented Y. pestis Δail mutant lysis. Protein quantification and number of CFU are means ± SE from two assays performed in duplicate on separate days; asterisks indicate statistical difference (ANOVA, P < 0.05).
Supernatant proteins released by Y. pestis KIM6+ Δail mutant during early stationary growth phase at 37°C
| Gene ID | ORF | Product | Function | No. of peptides | Protein coverage |
|---|---|---|---|---|---|
|
|
| Catalase peroxidase | Protection responses: detoxification | 12 | 24.9 |
|
|
| Lipoprotein | ABC-type nitrate/sulfonate/bicarbonate transport systems | 4 | 25.6 |
|
|
| F1 chaperone protein | Chaperones | 3 | 18.2 |
|
|
| Protease III precursor | Degradation of proteins, peptides | 3 | 5.2 |
|
|
| 2, 3, 4, 5-Tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase | Amino acid biosynthesis: lysine | 3 | 13.5 |
|
|
| 6-Phosphogluconate dehydrogenase | Energy metabolism, carbon: oxidative branch, pentose pathway | 3 | 9.5 |
|
|
| Thiol peroxidase | Protection responses: detoxification | 3 | 31.1 |
|
|
| Glutathionine S transferase | Biosynthesis of cofactors, carriers: thioredoxin, glutaredoxin, glutathione | 3 | 13.4 |
|
|
| Cysteine synthase A | Amino acid biosynthesis: cysteine | 3 | 17.4 |
|
|
| Elongation factor Tu | Proteins–translation and modification | 2 | 9.1 |
|
|
| Transketolase | Central intermediary metabolism: nonoxidative branch, pentose pathway | 2 | 4.1 |
|
|
| Aminopeptidase N | Degradation of proteins, peptides | 2 | 2.9 |
|
|
| Phosphopyruvate hydratase | Energy metabolism, carbon: glycolysis | 2 | 6.7 |
|
|
| Dihydrolipoamide dehydrogenase | Energy metabolism, carbon: E3 component of pyruvate and 2-oxoglutarate dehydrogenase complex | 2 | 6.7 |
|
|
| Chaperonin GroEL | Chaperones | 2 | 7.7 |
|
|
| Multifunctional fatty acid oxidation complex subunit alpha | Degradation of small molecules; fatty acids | 2 | 4.5 |
|
|
| Uridine phosphorylase | Salvage of nucleosides and nucleotides | 2 | 14.2 |
|
|
| Thioredoxin 1 | Biosynthesis of cofactors; carriers: thioredoxin, glutaredoxin, glutathione | 2 | 23.1 |
|
|
| Murine toxin | Lipid metabolism | 1 | 3.4 |
|
|
| F0F1 ATP synthase subunit beta | ATP-proton motive force interconversion | 1 | 3.9 |
|
|
| Superoxide dismutase | Protection responses: detoxification | 1 | 6.8 |
|
|
| 50S ribosomal protein L6 | Structural component; ribosomal proteins–synthesis, modification | 1 | 7.9 |
|
|
| Elongation factor G | Proteins–translation and modification | 1 | 2.0 |
|
|
| FKBP-type peptidyl-prolyl | Proteins–translation and modification | 1 | 4.7 |
|
|
| Ribulose-phosphate 3-epimerase | Central intermediary metabolism: nonoxidative branch, pentose pathway | 1 | 6.1 |
|
|
| Oligopeptidase A | Degradation of proteins, peptides | 1 | 1.5 |
|
|
| Transaldolase B | Central intermediary metabolism: nonoxidative branch, pentose pathway | 1 | 3.5 |
|
|
| Phosphoglycerate kinase | Energy metabolism, carbon: glycolysis | 1 | 4.4 |
|
|
| Elongation factor Ts | Proteins–translation and modification | 1 | 6.0 |
|
|
| Heat shock protein GrpE | Posttranslational modification, protein turnover, chaperones | 1 | 7.3 |
|
|
| Succinate dehydrogenase flavoprotein subunit | Energy metabolism, carbon: TCA cycle | 1 | 2.4 |
|
|
| Glutaredoxin 1 | Carrier; biosynthesis of cofactors, carriers: thioredoxin, glutaredoxin, glutathione | 1 | 12.6 |
|
|
| Outer membrane protein A | Outer membrane constituents | 1 | 3.6 |
|
|
| Arginyl-tRNA synthetase | Aminoacyl-tRNA synthetases, tRNA modification | 1 | 2.3 |
|
|
| Pyruvate kinase | Energy metabolism, carbon: glycolysis | 1 | 2.5 |
|
|
| Glyceraldehydes-3-phosphate dehydrogenase | Energy metabolism, carbon: glycolysis | 1 | 4.2 |
|
|
| Aconitate hydratase | Energy metabolism, carbon: TCA cycle | 1 | 1.5 |
|
| Hypothetical protein | Unknown; belongs to glutaredoxin (GRX) family | 1 | 10.7 | |
|
|
| Isocitrate dehydrogenase | Energy metabolism, carbon: TCA cycle | 1 | 3.5 |
|
| Putative aminotransferase | Amino acid biosynthesis: alanine | 1 | 3.9 | |
|
|
| Glucose specific PTS system component | Transport of small molecules; carbohydrates, organic acids, alcohols | 1 | 8.3 |
|
|
| ATP dependent Clp protease proteolytic subunit | Degradation of proteins, peptides | 1 | 9.2 |
|
|
| Riboflavin synthase subunit beta | Biosynthesis of cofactors, carriers: riboflavin | 1 | 12.2 |
|
| Putative peroxidase | Protection responses: detoxification | 1 | 5.5 | |
|
|
| Aminoacyl-histidine dipeptidase | Degradation of proteins, peptides | 1 | 2.9 |
|
|
| Phosphoheptose isomerase | Surface polysaccharides and antigens | 1 | 13.0 |
|
|
| Superoxide dismutase | Protection responses: detoxification | 1 | 12.8 |
|
|
| Pyruvate dehydrogenase subunit E1 | Energy metabolism, carbon: pyruvate dehydrogenase | 1 | 1.5 |
|
|
| Malate dehydrogenase | Energy metabolism, carbon: TCA cycle | 1 | 3.5 |
|
|
| Adenylosuccinate synthetase | Purine ribonucleotide biosynthesis | 1 | 2.8 |
|
|
| Acetyl-CoA synthetase | Fatty acid and phosphatidic acid biosynthesis | 1 | 1.8 |
|
|
| 50S ribosomal protein L11 | Structural component; ribosomal proteins - synthesis, modification | 1 | 9.9 |
|
|
| Elongation factor Tu | Proteins - translation and modification | 1 | 4.8 |
|
| Hypothetical protein | Unknown; potential TIM-barrel signal transduction protein | 1 | 7.5 | |
|
| Hypothetical protein | Unknown | 1 | 9.2 | |
|
|
| Stringent starvation protein A | Regulator of transcription; a RNA polymerase-associated protein | 1 | 6.6 |
|
| Isoprenoid biosynthesis protein | Unknown; putative factor | 1 | 12.4 | |
|
|
| Glucose-6-phosphate isomerase | Energy metabolism, carbon: glycolysis | 1 | 2.9 |
|
|
| Isocitrate lyase | Central intermediary metabolism: glyoxylate bypass | 1 | 3.4 |
Number of peptides identified for indicated protein.
Peptide coverage (%) of indicated protein.
FIG 4Y. pestis Δail mutant had no cell surface capsule protein (Caf1) unless glucose was added to the medium. Y. pestis KIM6+ wild type and the Δail mutant were grown with aeration to mid-logarithmic phase at 37°C in Luria-Bertani (LB) broth with or without 11 mM glucose. Cells were centrifuged, washed with PBS, and heat fixed on glass slides. Y. pestis cells (blue) were stained with DAPI, and Caf1 protein (red) was detected with mouse anti-Caf1 followed by goat anti-mouse Alexa Fluor 546 antibodies. Cells are at ×1,000 magnification and are representative of more than 20 microscopic fields.
FIG 5Mutations in the phospholipase A gene, pldA, suppressed lysis of Y. pestis Δail mutant at 37°C. Y. pestis KIM6+ wild type, the Δail mutant, the ΔpldA mutant, the catalytic site-specific PldAS164A mutant, complemented strains, and the indicated double mutants were grown with aeration to late stationary phase (24 h/37°C) in Luria-Bertani (LB) broth. (A) Cell-free supernatants from cultures were ethanol precipitated, separated by 12.5% SDS-PAGE, and stained with Coomassie blue. Protein bench mark standard positions are indicated on the left. Only the wild type or strains carrying pldA mutations did not release increased amounts of protein into the supernatants. (B) Strains were grown as described above for 48 h and CFU numbers determined by plate count. Only the wild type or strains carrying a pldA mutation did not lyse. (C) The protein contents of cell-free supernatants from the catalytic site-specific PldAS164A mutant and control cultures were quantified by Bradford assays. Only strains with an enzymatic phospholipase A (PldA) had increased amounts of protein released into the supernatants by Y. pestis Δail mutant. Results are means ± SE from two assays performed in duplicate on separate days; asterisks indicate significant difference by ANOVA (P < 0.05).
FIG 6Expression of pldA was repressed at 37°C and further decreased by glucose or Ca2+. Y. pestis KIM6+ wild type, the Δail mutant, and the Δail/ail complemented strain were transformed with the lux operon reporter under the control of the Y. pestis pldA promoter. Cells were grown with aeration to an OD600 of 1.0 at 28°C or 37°C in Luria-Bertani (LB) broth with or without 11 mM glucose or 2.5 mM CaCl2. Expression was measured spectrophotometrically as luminescence activity units (L.U.). Growth with glucose or Ca2+ repressed pldA expression at 37°C. Results are means ± SE from at least two assays performed in triplicate on separate days; an asterisk indicates significant difference between the growth conditions (two-way ANOVA, P < 0.05).
FIG 7Expression of the heat shock sigma factor promoters rpoE and rpoH was decreased in the Y. pestis Δail mutant at 37°C. Y. pestis KIM6+ wild type, the Δail mutant, and the Δail/ail complemented strain were grown with aeration to an OD600 of 1.0 at 28°C or 37°C in Luria-Bertani (LB) broth. Each strain was transformed with the lux operon reporter under the control of the Y. pestis rpoE (A) or rpoH (B) promoter. Expression was measured spectrophotometrically as luminescence activity units (L.U.). Results are means ± SE from at least three assays performed in triplicate on separate days; an asterisk indicates P < 0.05, and a double asterisk indicates P < 0.001 (Student's t test).
FIG 8Model of temperature-dependent Ail contribution to OM stabilization. Panel I shows conditions for maintaining OM asymmetry and cell lysis prevention at ambient temperature. Panel II, a, b, and c, compares the wild type and the Ail mutant for OM disruption and cell lysis at mammalian temperature. Panel II, d, e, and f, shows conditions that suppress cell lysis. OM, outer membrane; PS, periplasmic space; PG, peptidoglycan; IM, inner membrane; LOS, lipooligosaccharide; PL, phospholipid; lyso-PL, lysophospholipid; FA, fatty acid. Figure created with BioRender.com.
Bacteria
| Strain | Relevant genotype | Source or reference |
|---|---|---|
|
| ||
| CC1118 λ | R− M+λ |
|
| S17-1 λ | Δ |
|
| TOP10 | F−
| Invitrogen |
|
| ||
| KIM6+Nalr |
| |
| KIM6+Nalr
|
| |
| KIM6+Nalr
|
| |
| KIM6+Nalr
| This study | |
| KIM5 | S. C. Straley, University of Kentucky | |
| KIM5 | This study | |
| KIM5 | This study | |
| KIM6+ Nalr
| This study | |
| KIM6+Nalr
| This study | |
| KIM6+Nalr
| This study | |
| KIM6+Nalr
| This study | |
| KIM6+Nalr
| This study | |
| KIM6+Nalr
| This study | |
| Enteropathogenic | ||
|
| P. Feng, FDA | |
| O:8, | Laboratory collection |
Plasmids
| Plasmid | Relevant genotype | Source or reference |
|---|---|---|
| pCP20 | Temp-sensitive origin of replication and thermal induction of flippase synthesis; used to remove |
|
| pMHZ2 | Δ |
|
| pEPSacB1 |
| |
| pEPSacB1Kan | This study | |
| pTRC-Ail | Ail ( |
|
| pTRC- |
| |
| pTRC- |
| |
| pTRC- |
| |
| pMHZ4 | pEP | This study |
| pUTmini-Tn | Suicide plasmid for mini-Tn5 |
|
| pBR322 | Expression vector, Ampr Tetr | New England Biolabs, Inc. |
| pMHZ5 | pEP | This study |
| pUC19 | Backbone vector used to clone | New England Biolabs, Inc. |
| pPldAWT | This study | |
| pPldAS164A | Catalytic mutant version of pPldA, Ampr | This study |
| pBAD/HisA | Used as a template for cloning of the ampicillin resistance cassette, Ampr | Invitrogen |
| pACYC177- |
| |
| pACYC177-pmrls | Promoterless pACYC177- | This study |
| pACYC177- | This study | |
| pACYC177- | This study | |
| pACYC177- | This study | |
| pACYC177- | This study | |
| pACYC177- | This study | |
| pACYC177- | This study | |
| pDegP | R. Misra, Arizona State University | |
| pDegPS210A | R. Misra, Arizona State University | |
| pBA169 | pTrc99a ΔNcoI Ampr |
|
| pRC136 |
|
Primers
| Application and characteristics | Primer sequence(s) |
|---|---|
| Primers for the pMHZ2 Knr cassette with NotI and SmaI restriction sites | |
| Primers for | |
| Primers for | |
| Sequencing primer for identification of the Tn | |
| Primers for | |
| Primers for | |
| Primers for | |
| PldAS164A mutagenesis primers | |
| Sequencing primers to confirm PldAS164A point mutation | |
| Primers for 221-bp | |
| Primers for 187-bp | |
| Primers for 300-bp | |
| Sequencing primer for | |
| Primers for the Ampr cassette from pBAD/HisA with SacI restriction sites | |
F, forward; R, reverse.